An interventional study of Bone-Patellar Tendon-Bone Autograft ACL Reconstruction and Quadriceps Tendon Autograft ACL Reconstruction in Anterior Cruciate Ligament (ACL) Tear, sponsored by Hospital del Mar. Not yet recruiting. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Hospital del Mar · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This prospective, randomized, single-center, non-inferiority clinical trial will compare anterior knee pain (AKP) after primary anterior cruciate ligament (ACL) reconstruction using either a bone-patellar tendon-bone autograft (BPTB) or a quadriceps tendon autograft with a bone block (BQT).
Participants will be randomly assigned in a 1:1 ratio to one of the two graft groups. The primary objective is to determine whether BPTB is non-inferior to BQT with respect to AKP, as assessed by the change in pressure pain threshold from the preoperative measurement to 12 months after surgery.
Secondary outcomes will include kneeling pain, the Kujala Anterior Knee Pain Scale, the visual analog scale (VAS) for pain, quadriceps muscle circumference, the subjective International Knee Documentation Committee (IKDC) score, magnetic resonance imaging (MRI) findings, clinical stability, complications, associated surgical procedures, and graft failure.
174 studies on the registry are indexed under Lacerations; 42 are open to participants now.
This study's planned enrollment of 150 is above the median of 65 across 128 interventional studies indexed under Lacerations.
Browse Lacerations studies →Hospital del Mar is the lead sponsor of 45 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The criteria were revised on the registry on Oct 7, 2026. See what changed
Inclusion Criteria:
Clinical and/or radiological diagnosis of an anterior cruciate ligament (ACL) injury with an indication for primary surgical reconstruction.
Ability to understand the study information and provide written .
Willingness to participate in the study and complete the planned clinical and radiological follow-up.
Technical feasibility of performing either a bone-patellar tendon-bone (BPTB) autograft or a quadriceps tendon autograft, as determined by the treating surgeon.
Exclusion Criteria Previous surgery on the affected knee. Previous fracture of the proximal tibia, distal femur, or patella of the affected knee.
History of patellofemoral pain syndrome, symptomatic insertional patellar tendinopathy, or symptomatic insertional quadriceps tendinopathy.
Need to harvest a graft that does not meet the predefined study specifications. Presence of a pain-amplifying condition or generalized chronic pain that could interfere with the assessment of anterior knee pain.
Psychiatric, cognitive, or mental health disorders that may impair follow-up, understanding of the study, or valid completion of questionnaires.
Medical to surgery or magnetic resonance imaging (MRI). Refusal to participate or withdrawal of informed consent.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Bone-Patellar Tendon-Bone Autograft Arm Participants will undergo primary anterior cruciate ligament (ACL) reconstruction using a bone-patellar tendon-bone (BPTB) autograft harvested from the central portion of the patellar tendon, with bone blocks approximately 9-10 mm in diameter and 10-20 mm in length. The graft will be implanted using the standardized arthroscopic ACL reconstruction technique routinely performed at the study center.
Procedure: Bone-Patellar Tendon-Bone Autograft ACL Reconstruction
Quadriceps Tendon Autograft arm Participants will undergo primary anterior cruciate ligament reconstruction using a quadriceps tendon autograft with a bone block approximately 9-10 mm in diameter and 10-20 mm in length. The graft will be harvested as a partial-thickness graft using a standardized technique and implanted using the same standardized arthroscopic ACL reconstruction principles.
Procedure: Quadriceps Tendon Autograft ACL Reconstruction
BPTB Autograft ACL Reconstruction Primary ACL reconstruction using an autologous bone-patellar tendon-bone graft harvested from the central patellar tendon, with bone blocks approximately 9-10 mm in diameter and 10-20 mm in length. Graft harvest and reconstruction will be performed using a standardized arthroscopic technique
Quadriceps Tendon Autograft ACL Reconstruction Primary ACL reconstruction using an autologous quadriceps tendon graft with a bone block approximately 9-10 mm in diameter and 10-20 mm in length. The graft will be harvested as a partial-thickness quadriceps tendon graft using a standardized technique and implanted arthroscopically.
Change in Pressure Pain Threshold mesured with presure algometry at the center of the Patella
Time frame: Baseline to 12 months after surgery
No study locations are listed for this record.
Start is estimated for Oct 2026; primary completion for Oct 2028, 24 months later.
Of 46 non-industry interventional studies with no phase under Lacerations, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 72. This study's planned 24 months is above that.
Counting every sponsor, half of 50 studies reached it within 19 months; a quarter within 10 and three quarters within 72.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital del Mar